Development of selectively acting platinum complexes.
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis; D001943:Breast Neoplasms / Q000188:drug therapy; D002843:Chromatin / Q000378:metabolism; D004247:DNA / Q000378:metabolism; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007942:Leukemia, Experimental / Q000188:drug therapy; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D051379:Mice; D009690:Nucleic Acid Conformation / Q000187:drug effects; D009944:Organoplatinum Compounds / Q000138:chemical synthesis / Q000627:therapeutic use*; D010954:Plasmacytoma / Q000188:drug therapy; D011959:Receptors, Estradiol; D011960:Receptors, Estrogen / Q000378:metabolism; D013237:Stereoisomerism; D013629:Tamoxifen / Q000627:therapeutic use; D013936:Thymidine / Q000378:metabolism
D000970:Antineoplastic Agents; D002843:Chromatin; D009944:Organoplatinum Compounds; D011959:Receptors, Estradiol; D011960:Receptors, Estrogen; D013629:Tamoxifen; D004247:DNA; D013936:Thymidine